Metraipolis › archive › dc_e40ef733d450

Safety and Efficacy of Very Low-Dose Multi-Nut Oral Immunotherapy in Children — Europe PMC PMID:41385738

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41385738
DOI
10.1002/clt2.70125
License (as archived)
solo-consultazione
Archived
2026-11-08T01:35:36.408Z
SHA-256 of the archived text
3709e9c7d95a88bfd24b53240fe9ec578ebf9d705a59b0cc57af7035c9ec0e44
Stable URL of this page
https://metraipolis.com/documento/dc_e40ef733d450

How to cite

Safety and Efficacy of Very Low-Dose Multi-Nut Oral Immunotherapy in Children — Europe PMC PMID:41385738 — Europe PMC (en), https://europepmc.org/article/MED/41385738 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e40ef733d450 (Metraipolis archive dc_e40ef733d450, sha256 3709e9c7d95a88bfd24b53240fe9ec578ebf9d705a59b0cc57af7035c9ec0e44)
BibTeX
@misc{dce40ef733d450,
  title = {Safety and Efficacy of Very Low-Dose Multi-Nut Oral Immunotherapy in Children — Europe PMC PMID:41385738},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41385738},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e40ef733d450; sha256 3709e9c7d95a88bfd24b53240fe9ec578ebf9d705a59b0cc57af7035c9ec0e44},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41385738. Agents can read the archived copy with the MCP tool read_document.